HALEON PLC ADR (HLN)

Currency in USD
11.20
+0.04(+0.36%)
Closed·
11.200.00(0.00%)
·
Earnings results expected in 11 days
HLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.1311.26
52 wk Range
8.7111.42
Key Statistics
Prev. Close
11.16
Open
11.22
Day's Range
11.13-11.26
52 wk Range
8.71-11.42
Volume
8.11M
Average Volume (3m)
8.84M
1-Year Change
15.345%
Book Value / Share
2.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.82
Upside
+5.56%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

HALEON PLC ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

HALEON ADR Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Employees
24561

HALEON PLC ADR Earnings Call Summary for Q3/2025

  • Haleon reported Q3 2025 EPS of $0.1167, missing forecasts by 7.45%, with revenue slightly below expectations at $3.71B despite 3.4% organic growth
  • North American market challenges and Respiratory Health category declines offset strong performance in emerging markets, particularly India and Southeast Asia
  • Company completed a £500M share buyback for 2025 while stock traded near 52-week lows with modest 0.33% premarket increase
  • Management forecasts full-year organic revenue growth of 3.5% and high single-digit organic operating profit growth, with North America expected to return to growth in 2026
  • CFO Dawn Allen highlighted balanced growth between price (1.8%) and volume mix (1.6%), expressing confidence in clearing inventory levels by year-end
Last Updated: 30/10/2025, 10:50
Read Full Transcript

Compare HLN to Peers and Sector

Metrics to compare
HLN
Peers
Sector
Relationship
P/E Ratio
23.9x24.9x−0.5x
PEG Ratio
0.580.430.00
Price/Book
2.3x2.9x2.6x
Price / LTM Sales
3.3x2.7x3.3x
Upside (Analyst Target)
6.5%2.7%47.0%
Fair Value Upside
Unlock5.7%6.1%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 11.82
(+5.56% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Berenberg
Buy13.44+20.00%13.60Maintain07/11/2025
Berenberg
Buy13.41+19.73%13.48Maintain12/08/2025
Morgan Stanley
Buy10.95-2.23%11.25Maintain04/08/2025
BNP Paribas Exane
Buy13.40+19.64%-New Coverage27/05/2025
Morgan Stanley
Buy11.25+0.45%10.65Upgrade09/05/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.17%
Dividend Yield
1.62%
Industry Median 2.34%
Annualised payout
0.18
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
0.1228 / 0.1261
Revenue / Forecast
3.68B / 3.72B
EPS Revisions
Last 90 days

People Also Watch

28.97
NVST
+0.70%
22.46
WRBY
+5.10%
35.96
VCEL
+5.86%
13.36
ATEC
+1.98%
32.660
AROC
+2.80%

FAQ

What Is the HALEON ADR (HLN) Share Price Today?

The live HALEON ADR share price today is 11.20

What Stock Exchange Does HALEON ADR (HLN) Trade On?

HALEON ADR is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for HALEON ADR?

The stock symbol (also called a 'ticker') for HALEON ADR is "HLN."

Does HALEON ADR Pay Dividends? What’s The Current HLN Dividend Yield?

Yes, HLN Pays Dividends to its Shareholders. The current HALEON ADR dividend yield is 1.62%.

What Is the Current HALEON ADR Market Cap?

As of today, HALEON ADR market capitalisation is 49.75B.

What Is HALEON ADR's (HLN) Earnings Per Share (TTM)?

The HALEON ADR EPS is currently 0.17 (Trailing Twelve Months).

When Is the Next HALEON ADR Earnings Date?

HALEON ADR's next earnings report will be released on 25/02/2026.

Is HLN a Buy or Sell From a Technical Analyst Perspective?

Based on today's HALEON ADR moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has HALEON ADR Stock Split?

HALEON ADR has split 0 times. (See the HLN stock split history page for full effective split date and price information.)

How Many Employees Does HALEON ADR Have?

HALEON ADR has 24561 employees.

What is the current trading status of HALEON ADR (HLN)?

As of 14 Feb 2026, HALEON ADR (HLN) is trading at a price of 11.20, with a previous close of 11.16. The stock has fluctuated within a day range of 11.13 to 11.26, while its 52-week range spans from 8.71 to 11.42.

What Is HALEON ADR (HLN) Price Target According to Analysts?

The average 12-month price target for HALEON ADR is USD11.82, with a high estimate of USD13.44 and a low estimate of USD10. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +5.56% Upside potential.

What Is the HLN Premarket Price?

HLN's last pre-market stock price is 11.19. The pre-market share volume is 65,070.00, and the stock has decreased by 0.03, or 0.27%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.